Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner
Tóm tắt
Uroguanylin (UGN) is a 16 amino acid peptide produced mainly by intestinal epithelial cells. Nutrients intake increases circulating levels of prouroguanylin that is processed and converted to UGN to activate the guanylyl cyclase 2C receptor (GUCY2C). Given that the UGN-GUCY2C system has been proposed as a novel gut-brain endocrine axis regulating energy balance, the aim of the present study was to investigate the regulation of UGN protein levels in duodenum and circulating levels in lean and obese mice under different nutritional conditions and its potential interaction with leptin. Swiss, C57BL/6 wild-type and ob/ob male adult mice under different nutritional conditions were used: fed ad libitum standard diet (control); 48 h fasting (fasted); 48 h fasting followed by 24 h of feeding (refed); and fed high-fat diet (45 %) during 10 weeks. In addition, peripheral leptin administration was performed. Intestinal uroguanylin expression was studied by Western blot analysis; plasma levels were measured by ELISA. Food deprivation significantly reduced plasma UGN levels, which were correlated with the lower protein levels of UGN in duodenum. These effects were reverted after refeeding and leptin challenge. Consistently, in ob/ob mice UGN expression was decreased, whereas leptin treatment up-regulated UGN levels in duodenum in these genetically modified mice compared to WT. Diet-induced obese mice displayed increased UGN levels in intestine and plasma in comparison with lean mice. Our findings suggest that UGN levels are correlated with energy balance status and that the regulation of UGN by nutritional status is leptin-dependent.
Tài liệu tham khảo
Lancha A, Fruhbeck G, Gomez-Ambrosi J (2012) Peripheral signalling involved in energy homeostasis control. Nutr Res Rev 25:223–248. doi:10.1017/S0954422412000145
Dhillo WS, Bloom SR (2004) Gastrointestinal hormones and regulation of food intake. Horm Metab Res 36:846–851. doi 10.1055/s-2004-826174
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660. doi:10.1038/45230
Heppner KM, Chaudhary N, Muller TD, Kirchner H, Habegger KM, Ottaway N, Smiley DL, Dimarchi R, Hofmann SM, Woods SC, Sivertsen B, Holst B, Pfluger PT, Perez-Tilve D, Tschop MH (2012) Acylation type determines ghrelin’s effects on energy homeostasis in rodents. Endocrinology 153:4687–4695. doi:10.1210/en.2012-1194
Gahete MD, Rincon-Fernandez D, Villa-Osaba A, Hormaechea-Agulla D, Ibanez-Costa A, Martinez-Fuentes AJ, Gracia-Navarro F, Castano JP, Luque RM (2014) Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight. J Endocrinol 220:R1–R24. doi:10.1530/JOE-13-0391
Kirchner H, Heppner KM, Holland J, Kabra D, Tschop MH, Pfluger PT (2013) Ablation of ghrelin O-acyltransferase does not improve glucose intolerance or body adiposity in mice on a leptin-deficient ob/ob background. PLoS ONE 8:e61822. doi:10.1371/journal.pone.0061822
Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908–913. doi:10.1038/35038090
Hamra FK, Forte LR, Eber SL, Pidhorodeckyj NV, Krause WJ, Freeman RH, Chin DT, Tompkins JA, Fok KF, Smith CE et al (1993) Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci USA 90:10464–10468
Seeley RJ, Tschop MH (2011) Uroguanylin: how the gut got another satiety hormone. J Clin Investig 121:3384–3386. doi:10.1172/JCI58297
Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, Waldman SA (1996) Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci USA 93:14827–14832
Carrithers SL, Parkinson SJ, Goldstein S, Park P, Robertson DC, Waldman SA (1994) Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology 107:1653–1661
Swenson ES, Mann EA, Jump ML, Witte DP, Giannella RA (1996) The guanylin/STa receptor is expressed in crypts and apical epithelium throughout the mouse intestine. Biochem Biophys Res Commun 225:1009–1014. doi:10.1006/bbrc.1996.1286
Kim GW, Lin JE, Waldman SA (2013) GUCY2C: at the intersection of obesity and cancer. Trends Endocrinol Metabol 24:165–173. doi:10.1016/j.tem.2013.01.001
London RM, Krause WJ, Fan X, Eber SL, Forte LR (1997) Signal transduction pathways via guanylin and uroguanylin in stomach and intestine. Am J Physiol 273:G93–G105
Perkins A, Goy MF, Li Z (1997) Uroguanylin is expressed by enterochromaffin cells in the rat gastrointestinal tract. Gastroenterology 113:1007–1014
Nakazato M, Yamaguchi H, Date Y, Miyazato M, Kangawa K, Goy MF, Chino N, Matsukura S (1998) Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin. Endocrinology 139:5247–5254. doi:10.1210/endo.139.12.6347
Valentino MA, Lin JE, Snook AE, Li P, Kim GW, Marszalowicz G, Magee MS, Hyslop T, Schulz S, Waldman SA (2011) A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. J Clin Investig 121:3578–3588. doi:10.1172/JCI57925
Imbernon M, Sanchez-Rebordelo E, Gallego R, Gandara M, Lear P, Lopez M, Dieguez C, Nogueiras R (2014) Hypothalamic KLF4 mediates leptin’s effects on food intake via AgRP. Mol Metabol 3:441–451. doi:10.1016/j.molmet.2014.04.001
Perez-Sieira S, Lopez M, Nogueiras R, Tovar S (2014) Regulation of NR4A by nutritional status, gender, postnatal development and hormonal deficiency. Sci Rep 4:4264. doi:10.1038/srep04264
Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314
Begg DP, Steinbrecher KA, Mul JD, Chambers AP, Kohli R, Haller A, Cohen MB, Woods SC, Seeley RJ (2014) Effect of guanylate cyclase-C activity on energy and glucose homeostasis. Diabetes. doi:10.2337/db14-0160
Schulz S, Chrisman TD, Garbers DL (1992) Cloning and expression of guanylin. Its existence in various mammalian tissues. J Biol Chem 267:16019–16021
Miyazato M, Nakazato M, Matsukura S, Kangawa K, Matsuo H (1996) Uroguanylin gene expression in the alimentary tract and extra-gastrointestinal tissues. FEBS Lett 398:170–174
Williams LM (2012) Hypothalamic dysfunction in obesity. Proc Nutr Soc 71:521–533. doi:10.1017/S002966511200078X